ArticleBMJ case reports2025

Multiday intravenous ketamine infusion therapy for the management of central sensitisation syndrome secondary to chronic chemotherapy-induced peripheral neuropathic pain.

Mohammad Abdullah et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.